Masters, Integrated Masters in Natural or Agricultural or Pharmaceutical Sciences MVSc, Animal Sciences.
OR Bachelors degree in Engineering or Technology or Medicine from a recognized University or equivalent. AND 2 years experience in Research and Development in Industrial and Academic Institutions or Science and Technology Organizations and Scientific activities and services.
Pursuing B.Sc, B.Tech, B.Pharma Microbiology, Biotechnology any branch of Life Sciences; M.Sc, M.Tech, M.Pharm Microbiology, Biotechnology any branch of Life Sciences.
B.Pharmacy from a recognized institute OR 10 plus 2 with science stream from a recognized Beard And
Approved Diploma in Pharmacy from an Institute recognized by the pharmacy council of India and registered as pharmacist under the pharmacy Act 1948
Aspiring interns should be in the pre-final or final year of their Masters M.E, M.Tech, M.Sc or Bachelors degree course B.E, B.Tech, B.Sc in India in Life Sciences, Biotechnology, that are relevant to the research projects at CBR.
Applicants should hold a Ph.D. degree and should have research publications in cell biology and, or molecular genetics, developmental biology, preferably using Drosophila model. Those who have submitted their doctoral thesis and are awaiting results may also apply.
Responsible for upkeep of Encapsulation area in Production and Supervising area in production. Preparation and review of SOPs and other documentation in manufacturing areas.
ANNORA Pharma is committed to provide medicines with highest quality, safety and efficacy that meets the needs of the customers with applicable statutory and regulatory requirements.
Finecure Pharmaceuticals Limited and its subsidiaries are leading manufacturers and marketers of Pharmaceutical formulations and Nutraceuticals in several therapeutic segments in dosage forms of Tablets, Capsules, Oral Liquids, Dry Syrup, Powders, Injections and Sachet.
Lincoln Pharmaceuticals Ltd., Ahmedabad based 40 years old, public limited having presence in 75+ countries, 1700+ registered products, own Manufacturing and R&D center and among india’s top 70 pharma company.
Drug patent expiration presents a significant opportunity for the launch of generic medications, which can dramatically alter market dynamics. When a branded drug's patent expires, it opens the door for generic manufacturers to produce and sell bioequivalent versions at a lower cost, leading to increased competition and reduced prices. This not only makes medications more accessible to patients but also creates substantial market opportunities for generic pharmaceutical companies.